Markets
News
Analysis
User
24/7
Economic Calendar
Education
Data
- Names
- Latest
- Prev
A:--
F: --
P: --
A:--
F: --
P: --
A:--
F: --
A:--
F: --
A:--
F: --
P: --
A:--
F: --
P: --
A:--
F: --
P: --
A:--
F: --
P: --
A:--
F: --
P: --
A:--
F: --
P: --
A:--
F: --
P: --
A:--
F: --
P: --
A:--
F: --
P: --
A:--
F: --
P: --
A:--
F: --
P: --
A:--
F: --
P: --
A:--
F: --
P: --
A:--
F: --
P: --
A:--
F: --
P: --
A:--
F: --
P: --
A:--
F: --
P: --
A:--
F: --
P: --
A:--
F: --
P: --
A:--
F: --
P: --
A:--
F: --
P: --
A:--
F: --
A:--
F: --
P: --
A:--
F: --
P: --
--
F: --
P: --
--
F: --
P: --
--
F: --
P: --
--
F: --
P: --
--
F: --
P: --
--
F: --
P: --
--
F: --
P: --
--
F: --
P: --
--
F: --
P: --
--
F: --
P: --
--
F: --
P: --
--
F: --
P: --
--
F: --
P: --
--
F: --
P: --
--
F: --
P: --
--
F: --
P: --
--
F: --
P: --
--
F: --
P: --
--
F: --
P: --
--
F: --
P: --
--
F: --
P: --
--
F: --
P: --
--
F: --
P: --
--
F: --
P: --
--
F: --
P: --
--
F: --
P: --
--
F: --
P: --
--
F: --
P: --
No matching data
Latest Views
Latest Views
Trending Topics
To quickly learn market dynamics and follow market focuses in 15 min.
In the world of mankind, there will not be a statement without any position, nor a remark without any purpose.
Inflation, exchange rates, and the economy shape the policy decisions of central banks; the attitudes and words of central bank officials also influence the actions of market traders.
Money makes the world go round and currency is a permanent commodity. The forex market is full of surprises and expectations.
Top Columnists
Enjoy exciting activities, right here at FastBull.
The latest breaking news and the global financial events.
I have 5 years of experience in financial analysis, especially in aspects of macro developments and medium and long-term trend judgment. My focus is maily on the developments of the Middle East, emerging markets, coal, wheat and other agricultural products.
BeingTrader chief Trading Coach & Speaker, 8+ years of experience in the forex market trading mainly XAUUSD, EUR/USD, GBP/USD, USD/JPY, and Crude Oil. A confident trader and analyst who aims to explore various opportunities and guide investors in the market. As an analyst I am looking to enhance the trader’s experience by supporting them with sufficient data and signals.
Latest Update
Risk Warning on Trading HK Stocks
Despite Hong Kong's robust legal and regulatory framework, its stock market still faces unique risks and challenges, such as currency fluctuations due to the Hong Kong dollar's peg to the US dollar and the impact of mainland China's policy changes and economic conditions on Hong Kong stocks.
HK Stock Trading Fees and Taxation
Trading costs in the Hong Kong stock market include transaction fees, stamp duty, settlement charges, and currency conversion fees for foreign investors. Additionally, taxes may apply based on local regulations.
HK Non-Essential Consumer Goods Industry
The Hong Kong stock market encompasses non-essential consumption sectors like automotive, education, tourism, catering, and apparel. Of the 643 listed companies, 35% are mainland Chinese, making up 65% of the total market capitalization. Thus, it's heavily influenced by the Chinese economy.
HK Real Estate Industry
In recent years, the real estate and construction sector's share in the Hong Kong stock index has notably decreased. Nevertheless, as of 2022, it retains around 10% market share, covering real estate development, construction engineering, investment, and property management.
Hongkong, China
Ho Chi Minh, Vietnam
Dubai, UAE
Lagos, Nigeria
Cairo, Egypt
White Label
Data API
Web Plug-ins
Affiliate Program
View All
No data
Not Logged In
Log in to access more features
FastBull Membership
Not yet
Purchase
Log In
Sign Up
Hongkong, China
Ho Chi Minh, Vietnam
Dubai, UAE
Lagos, Nigeria
Cairo, Egypt
White Label
Data API
Web Plug-ins
Affiliate Program
Although U.S. stocks closed mixed on Tuesday, there were a few notable insider trades.
When insiders purchase shares, it indicates their confidence in the company’s prospects or that they view the stock as a bargain. Either way, this signals an opportunity to go long on the stock. Insider purchases should not be taken as the only indicator for making an investment or trading decision. At best, it can lend conviction to a buying decision.
Below is a look at a few recent notable insider purchases. For more, check out Benzinga’s insider transactions platform.
BJ’s Wholesale
Global Partners
SR Bancorp
Read Next:
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Reporter Name | Global Gp Llc |
Relationship | Other |
Type | Purchase |
Amount | $521,110 |
SEC Filing | Form 4 |
Global GP LLC, as the reporter shareholder, has purchased a total of 12,100 common units representing limited partner interests in GLOBAL PARTNERS LP. These transactions occurred over three dates: 2024-09-13, 2024-09-16, and 2024-09-17, with a total purchase amount of $521,110. The price per share for these purchases was reported as a weighted average, ranging from $42.84 to $43.6 across the different transaction dates. Following these transactions, Global GP LLC directly owns 261,081 common units. The purchases were made to satisfy obligations under the Global Partners LP Long-Term Incentive Plan (LTIP), with the reporter disclaiming any pecuniary interest in the securities.
SEC Filing: GLOBAL PARTNERS LP [ GLP ] - Form 4 - Sep. 17, 2024
Reporter Name | Ortega Steven L |
Relationship | Director |
Type | Purchase |
Amount | $199,493 |
SEC Filing | Form 4 |
Steven L Ortega, serving as a Director at BJ's Wholesale Club Holdings, has purchased 2,455 shares of Common Stock on September 16, 2024. The transaction was executed at a weighted average price of $81.26 per share, totaling $199,493. Following this purchase, Ortega directly owns 6,901 shares of the company. The price range for the shares was from $81.20 to $81.27.
SEC Filing: BJ's Wholesale Club Holdings, Inc. [ BJ ] - Form 4 - Sep. 17, 2024
On CNBC's “Halftime Report Final Trades,” Stephen L. Weiss of Short Hills Capital Partners recommended buying TransDigm Group Incorporated .
On Aug. 6, TransDigm Group reported better-than-expected third-quarter financial results and raised its FY24 guidance above estimates.
Jason Snipe of Odyssey Capital Advisors said BJ’s Wholesale Club Holdings, Inc. beat on the bottom line.
On Aug. 22, BJ’s Wholesale reported better-than-expected second-quarter financial results. Revenue growth of 4.9% Y/Y to $5.205 billion, beating the analyst consensus estimate of $5.145 billion. Total comparable club sales increased by 3.1%. Comparable club sales, excluding gasoline sales, increased by 2.4%.
Don't forget to check out our premarket coverage here
Anastasia Amoroso of iCapital picked VanEck Semiconductor ETF , saying semiconductor space is down 17%, so it's a good place to add.
Joe Terranova of Virtus Investment Partners named AbbVie Inc. as his final trade.
On Sept. 10, AbbVie’s CONSTELLA received Health Canada approval for treating childhood constipation. “Constipation is a common issue in childhood that can significantly impact a child’s quality of life and cause considerable stress for their families. These children and families will be grateful to have a new prescription treatment option that can offer symptom relief and improve the overall well-being of the child and family, making daily life more manageable,” said Dr. Melanie Schmidt, Division of Paediatric Gastroenterology and Hepatology at Children’s Hospital in London, Ontario.
Price Action:
Check This Out:
Image generated using artificial intelligence via Midjourney.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Cannabis stocks have emerged as an unlikely bipartisan favorite ahead of the November presidential elections. While Vice President Kamala Harris has previously backed rescheduling marijuana under less restrictive Schedule III guidelines, GOP candidate Donald Trump has now also voiced his support for the issue in Florida. As cannabis operators continue to await more business-friendly U.S. policies on everything from taxation to employment to banking, investors are becoming optimistic that a significant shift could be coming for the domestic market.
Against this backdrop, here's a look at three promising cannabis stocks for investors to consider - Organigram Holdings , Verano Holding , and Cresco Labs . All three stocks trade under $10 per share, with a consensus "buy" or better rating from analysts, presenting lower-priced opportunities for lucrative returns in a sector that's poised for rapid growth and transformation.
#1. Organigram Holdings
Based in Canada, Organigram Holdings is a leading producer of high-quality medical and recreational cannabis. The company specializes in producing indoor-grown cannabis, utilizing innovative production techniques to meet consumer needs in both the medical sector and adult-use recreational markets.
Valued at $192 million by market cap, shares of Organigram have rallied over 41% YTD, outpacing the broader S&P 500 Index's gain of nearly 18%. OGI shares are now trading at a reasonable 1.72 price/sales (P/S) ratio, significantly lower than the sector median of 3.89 and its own 5-year average of 4.68.
In its fiscal Q3 results, announced on Aug. 13, revenue swelled to $30 million, surpassing Wall Street's estimate by $1.12 million and marking a 24.2% increase year over year. Most impressively, OGI reported a profitable quarter, with net income of $2.1 million surpassing Wall Street's forecast for a quarterly loss. On an adjusted basis, the company earned a profit of $0.03, marking the first time the firm has been profitable on a quarterly basis.
This outperformance is mainly attributed to cost cutting, though the company is still eyeing new opportunities. Organigram has delivered $7.9 million so far of its targeted $10 million in cost savings for fiscal 2024, and says it's on pace to achieve its target for the full year.
Looking ahead, OGI is targeting a move into the German market, where adult use was recently expanded, with its strategic $21 million investment into Sanity Group, which has the No. 2 flower brand in the German market and operates two dispensaries in Switzerland.
Analysts are predicting Organigram's revenue will rise 15.4% next fiscal year to reach $135.25 million, though the cannabis company isn't expected to reach consistent profitability for several more years - making this penny stock a riskier bet.
Overall, Organigram has a consensus "Moderate Buy" rating from four analysts in coverage. Two rate the stock a "Strong Buy," one says it's a "Moderate Buy," and one has a "Hold" rating.
The average 12-month price target for OGI is $2.95, implying a 58.6% upside potential from the current price.
#2. Verano Holdings
Based in Chicago, Verano Holdings is a multi-state operator in the cannabis industry, specializing in the cultivation, manufacturing, and retailing of premium cannabis products. The company operates numerous dispensaries across the United States, catering to both medical and recreational users.
Valued at $1.10 billion, shares of this cannabis company have plunged more than 28% YTD, largely due to revenue that did not meet expectations in the most recent quarter. Following this pullback, VRNOF shares currently trade at a price/sales ratio of just 1.25, suggesting the cannabis stock is relatively cheap at current levels.
In its Q2 earnings, Verano reported net revenue of $222 million, marking a 5% decline from the previous year, and falling short of expectations. However, the adjusted quarterly loss of $0.03 per share was narrower than expected.
Verano Holdings is also eyeing strategic expansions. The company has significantly increased its footprint in Florida, opening new dispensaries in Melbourne and Okeechobee, bringing its total to 79 in the state and 152 nationwide. This expansion not only enhances its market presence but also improves access to its products for a larger customer base, which could lead to increased sales and potentially better financial outcomes in future quarters.
Moreover, Verano is actively participating in advocacy efforts to legalize adult-use cannabis in Florida, which could lead to substantial market expansion. Their support for the Smart and Safe Florida campaign underscores their commitment to influencing favorable legislative outcomes that could benefit both the company and the industry at large.
Looking ahead, analysts tracking the company expect Verano Holdings to hit $1 billion in revenue in fiscal year 2025.
Out of seven analysts in coverage, the consensus is a "strong buy" rating. This bullish group's mean price target of $8.50 indicates expected upside potential of 160% from current levels.
#3. Cresco Labs
Another Chicago-based company, Cresco Labs is a multi-state cannabis operator that cultivates and manufactures products for both medical and adult use. Recently, Cresco announced the retirement of CFO Dennis Olis, who has been with the organization since July 2020. Olis will be succeeded in the role by Sharon Schuler, a cannabis industry newcomer who brings deep financial expertise from her time at BJ's Wholesale , The TJX Companies , and more large organizations.
With a market cap of $810 million, shares of Cresco have rallied over 26% YTD, surpassing the broader market with ease.
Cresco currently trades at just a 0.78 P/S ratio, which is a nearly 70% discount to its own 5-year average valuation - presenting an attractive entry point for prospective investors.
On Aug. 8, the company unveiled its Q2 earnings for 2024, which missed analysts' expectations on both the top and bottom lines. Net revenue came in at $184 million, showing almost flat growth from the previous quarter, while the loss per share of $0.15 was wider than anticipated. The quarterly net loss of $51.18 million was influenced by a substantial $61 million tax charge.
However, Cresco achieved an impressive 52% adjusted gross profit margin and a 29% adjusted EBITDA margin, signaling robust operational efficiency. This strong operational performance was led by its Sunnyside dispensaries, which retained a leading market share in Illinois, Pennsylvania, and Massachusetts - all key competitive markets.
Cresco Labs has strategically focused on maintaining operational efficiencies and expanding into potential adult-use cannabis markets, anticipating significant revenue growth in the coming years. They also anticipate cash savings from tax benefits due to expected legislative changes in cannabis regulations.
Wall Street analysts are overall bullish on Cresco stock, as the seven experts in coverage have assigned an average "strong buy" rating, with the mean price target of $3.48 indicating over 107% upside potential.
While investing in these cannabis stocks is still risky, given the broader regulatory uncertainty, investors with a high tolerance for volatility and the patience to hold these names for the long term may ultimately be rewarded by favorable policy outcomes.
On the date of publication, Nauman Khan did not have (either directly or indirectly) positions in any of the securities mentioned in this article. All information and data in this article is solely for informational purposes. For more information please view the Barchart Disclosure Policy here.
Reporter Name | Global Gp Llc |
Relationship | Other |
Type | Purchase |
Amount | $426,466 |
SEC Filing | Form 4 |
Global GP LLC reported purchasing 9,800 common units representing limited partner interests in GLOBAL PARTNERS LP over two transactions on September 10 and 11, 2024, for a total amount of $426,466. The purchases were made at weighted average prices of $43.17 and $43.85 per share, respectively. Following these transactions, Global GP LLC directly owns 248,981 common units. The acquisitions were made to satisfy obligations under the Global Partners LP Long-Term Incentive Plan, with the reporter disclaiming any pecuniary interest in these securities.
SEC Filing: GLOBAL PARTNERS LP [ GLP ] - Form 4 - Sep. 12, 2024
White Label
Data API
Web Plug-ins
Poster Maker
Affiliate Program
The risk of loss in trading financial instruments such as stocks, FX, commodities, futures, bonds, ETFs and crypto can be substantial. You may sustain a total loss of the funds that you deposit with your broker. Therefore, you should carefully consider whether such trading is suitable for you in light of your circumstances and financial resources.
No decision to invest should be made without thoroughly conducting due diligence by yourself or consulting with your financial advisors. Our web content might not suit you since we don't know your financial conditions and investment needs. Our financial information might have latency or contain inaccuracy, so you should be fully responsible for any of your trading and investment decisions. The company will not be responsible for your capital loss.
Without getting permission from the website, you are not allowed to copy the website's graphics, texts, or trademarks. Intellectual property rights in the content or data incorporated into this website belong to its providers and exchange merchants.